LexDanaLexDanabeta
Inventor

Klaus Dembowsky

Inventor
Boston, MA, US

Overview

45→
Patents
1996–2012
Patent span
Chemistry
Primary field (CPC C)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
A61KPreparations for medical, dental or toiletry purposes8%
C07CAcyclic or carbocyclic compounds6%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
8,242,281'Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands'20127,855,219'Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereof'20107,825,255'Adenosine receptor selective modulators'20107,781,470'Aminodicarboxylic acid derivatives having pharmaceutical properties'20107,704,999'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'20107,696,206'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'20107,674,825'Dicarboxylic acid derivatives with pharmaceutical properties'20107,517,896'Aminodicarboxylic acid derivatives having pharmaceutical properties'20097,504,421'Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use'20097,317,016'Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives'20087,314,871'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension'20087,291,622'Medical uses of carbamate-substituted pyrazolo-pyridine derivatives'20077,135,486'Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof'20067,129,255'Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor'20067,122,540'2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'20067,115,599'Sulfonamide-substituted pyrazolopyridine compounds'20067,098,207'Imidazotriazinones and the use thereof'20067,091,203'Imidazo[1,3,5]triazinones and their use'20067,087,644'Derivatives of dicarboxylic acid having pharmaceutical properties'20067,078,417'Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations'20066,943,163'7-Alkyl and cycloalkyl-substituted imidazotriazinones'20056,919,345'Sulfonate substituted pyrazol pyridine derivatives'20056,903,089'Lactam-substituted pyrazolopyridine derivatives'20056,890,922'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'20056,878,708'Imidazotriazinones and the use thereof'20056,864,287'Derivatives of dicarboxylic acid having pharmaceutical properties'20056,838,459'7-alkyl-and cycloalkyl-substituted imidazotriazinones'20056,833,364'Substituted pyrazole derivatives'20046,803,365'Imidazo1,3,5triazinones and the use thereof'20046,777,416'Isoxazolo pyrimidinones and the use thereof'20046,743,798'Substituted pyrazole derivatives condensed with six-membered heterocyclic rings'20046,693,102'Pyridine-substituted pyrazolopyridine derivatives'20046,683,081'Triazolotriazinones and the use thereof'20046,566,360'2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors'20036,476,029'7-alkyl- and cycloalkyl-substituted imidazotriazinones'20026,462,068'Heterocyclylmethyl-substituted pyrazole derivatives'20026,451,805'Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases'20026,414,009'Heterocyclylmethyl-substituted pyrazol derivatives'20026,410,740'Heterocyclylmethyl-substituted pyrazol derivatives'20026,387,940'Heterocyclylmethyl-substituted pyrazole derivatives'20026,362,178'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'20026,180,656'Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems'20016,166,027'Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases'20005,721,248'4-bicyclically substituted dihydropyridines, and their use in medicaments'19985,545,646'4-bicyclically substituted dihydropyridines and their use in medicaments'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2010Patents assigned to BAYER AG (32)· patent assignee history
1996–1998Based in Wuppertal, DE· patent location history
2000–2004Based in Schriesheim, DE· patent location history
2002–2012Based in Boston, MA, US· patent location history
2004–2006Patents assigned to BAYER HEALTHCARE AG (4)· patent assignee history
2005–2006Based in Munich, DE· patent location history
2008Based in München, DE· patent location history
2009–2012Patents assigned to DEMBOWSKY KLAUS (2)· patent assignee history
2009–2012Patents assigned to KRAHN THOMAS (2)· patent assignee history
2010Patents assigned to BAYER SCHERING PHARMA AG (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG321996–2010
BAYER SCHERING PHARMA AG52010
BAYER HEALTHCARE AG42004–2006
DEMBOWSKY KLAUSself22009–2012
KRAHN THOMAS22009–2012
Locations
LocationPatentsSpan
Boston, Massachusetts, US322002–2012
Schriesheim, DE82000–2004
Munich, DE22005–2006
Wuppertal, DE21996–1998
München, DE12008